Back to top

Bearish MACD for Supernus Pharmaceuticals Inc.

Read MoreHide Full Article

Supernus Pharmaceuticals Inc.’s (SUPN - Free Report) MACD indicator has moved into bearish territory with a reading of –0.3009. The Zacks Rank #4 (“Sell”) stock decreased more than 0.19% to $5.19 in morning trade. The Zacks Consensus Estimate on the company’s loss for the year ending December 2013 has increased by 28 cents over the past month to a loss of $2.27 per share.


In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Supernus Pharmaceuticals, Inc. (SUPN) - free report >>

More from Zacks Tale of the Tape

You May Like